Wall St. extends run of record highs; services data upbeat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Wells Fargo (WFC) PT Raised to $57 at UBS on 3Q17 U.S. Banking Preview; 'Economic Growth Conditions to Drive Bank Stocks'
October 6, 2017 10:11 AM EDTUBS raised its price target on Wells Fargo (NYSE: WFC) to $57.00 (from $56.00) while maintaining a Neutral rating, following a third quarter 2017 U.S. Banking preview.
Analyst Saul Martinez notes a positive outlook following the third quarter 2017 U.S. Banking preview, as the... More
Netflix (NFLX) PT Raised to $225 at Rosenblatt Following Announced Price Increase
October 6, 2017 9:27 AM EDTRosenblatt raised its price target on Netflix (NASDAQ: NFLX) to $225.00 (from $200.00) while maintaining a Buy rating following the company's announcement that it will be raising prices in the US. The company will raise prices by 10% on its most popular service, 17% on its... More
Netflix (NFLX) PT Raised to $180 at Jefferies Following Announced Priceing Move
October 6, 2017 7:04 AM EDTJefferies raised its price target on Netflix (NASDAQ: NFLX) to $180.00 (from $165.00) while maintaining a Hold rating. The company plans to raise the price of its standard / premium plans by $1 / $2 per mo., respectively. Press reports indicate that the new prices will take place immediately for new US... More
Teva Pharma (TEVA) PT Lowered to $15 at Morgan Stanley
October 5, 2017 8:58 AM EDTMorgan Stanley lowered its price target on Teva Pharma (NYSE: TEVA) to $15.00 (from $16.00) while maintaining a Underweight rating.
... MoreTeva Pharma (TEVA) PT Lowered to $21 at Barclays; Generic Copaxone 40mg Approval 'Will Offset Some Contracting Strategies... Hurt Sentiment'
October 4, 2017 12:17 PM EDTBarclays lowered its price target on Teva Pharma (NYSE: TEVA) to $21.00 (from $23.00) while maintaining a Equalweight rating, following an update on the U.S. Specialty Pharmaceutical industry, as the FDA recently approved a generic Copaxone formulation.
Analyst Douglas Tsao notes a... More
Mylan (MYL) PT Raised to $36 at Cowen; Reiterates Market Perform
October 4, 2017 10:44 AM EDTCowen raised its price target on Mylan (NASDAQ: MYL) to $36.00 (from $30.00) while maintaining a Market Perform rating. Cowen updated its model to reflect a potential $800MM in generic Copaxone contribution in 2018, and then modestly declining with other competition.
With this approval the... More
